Melfa Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $551K | Hold |
6,645
| – | – | 0.35% | 71 |
|
|
2025
Q1 | $539K | Hold |
6,645
| – | – | 0.36% | 71 |
|
|
2024
Q4 | $598K | Hold |
6,645
| – | – | 0.4% | 65 |
|
|
2024
Q3 | $657K | Hold |
6,645
| – | – | 0.43% | 58 |
|
|
2024
Q2 | $616K | Hold |
6,645
| – | – | 0.43% | 59 |
|
|
2024
Q1 | $631K | Hold |
6,645
| – | – | 0.46% | 55 |
|
|
2023
Q4 | $593K | Buy |
6,645
+1
| +0% | +$89 | 0.56% | 47 |
|
|
2023
Q3 | $485K | Hold |
6,644
| – | – | 0.53% | 51 |
|
|
2023
Q2 | $553K | Hold |
6,644
| – | – | 0.56% | 49 |
|
|
2023
Q1 | $506K | Hold |
6,644
| – | – | 0.51% | 50 |
|
|
2022
Q4 | $551K | Buy |
+6,644
| New | +$551K | 0.58% | 48 |
|